Last news
Datasea Pre-Announces Second Quarter Revenue of $20.5 Million, up 81% Year-over-Year

Datasea Pre-Announces Second Quarter Revenue of $20.5 Million, up 81% Year-over-Year

Gross Profit achieved a 310% Increase Year-over-Year BEIJING, Feb. 5, 2025 /PRNewswire/ -- Datasea Inc. (Nasdaq: DTSS) ("Datasea" or "the Company"), a Nevada-based digital technology company specializing in acoustics high-tech and 5G+AI multimodal...

Actinogen announces new and unique nonproprietary name of 'emestedastat' for Xanamem

Actinogen announces new and unique nonproprietary name of 'emestedastat' for Xanamem

Late-stage Alzheimer's trial opens 10 new sites in USA, with results due in 2025 and 2026 SYDNEY, Feb. 5, 2025 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) announces that the World Health Organization (WHO) has granted the nonproprietary...

Supermicro Ramps Full Production of NVIDIA Blackwell Rack-Scale Solutions with NVIDIA HGX B200

Supermicro Ramps Full Production of NVIDIA Blackwell Rack-Scale Solutions with NVIDIA HGX B200

Supermicro Offers Next-Generation Air-Cooled and Liquid-Cooled Architecture for NVIDIA Blackwell Platform SAN JOSE, Calif., Feb. 5, 2025 /PRNewswire/ -- Supermicro, Inc. (NASDAQ: SMCI), a Total IT Solution Provider for AI/ML, HPC, Cloud, Storage,...

Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Serplulimab is the world's first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC Serplulimab is the first and only anti-PD-1 mAb approved in the European Union (EU) for the treatment of ES-SCLC Serplulimab has now...

NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 5th

NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 5th

NEW YORK, Feb. 5, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins....

TUMI UNVEILS MULTI-YEAR PARTNERSHIP WITH MASTER & DYNAMIC

TUMI UNVEILS MULTI-YEAR PARTNERSHIP WITH MASTER & DYNAMIC

Introducing 19 Degree-inspired earphones, blending iconic TUMI design with premium sound technology NEW YORK, Jan. 29, 2025 /PRNewswire/ -- Today, international travel and lifestyle brand TUMI announces an exciting collaboration with premium audio...

I Peace establishes and offers low immunoreaction risk GMP iPS Cells

I Peace establishes and offers low immunoreaction risk GMP iPS Cells

Three lines of GMP iPS Cells derived from type O female blood are now offered as off-the-shelf product PALO ALTO, Calif., Feb. 5, 2025 /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. (https://ipeace.com/en/), specializing in induced pluripotent...

TRILLER PUTS CREATORS FIRST AS IT UNLEASHES THE FUTURE OF TECH, MUSIC & CULTURE WITH THE LATEST VERSION OF ITS APP

TRILLER PUTS CREATORS FIRST AS IT UNLEASHES THE FUTURE OF TECH, MUSIC & CULTURE WITH THE LATEST VERSION OF ITS APP

Powered by next-generation technology and with data privacy front and center, Triller is redefining the creator economy with new ways for brands and creators to own their content, connect with their fans, and manage their audiences LOS ANGELES, Feb....

menu
menu